| 2025-10-23 |
详情>>
业绩披露：
2025年三季报(累计)每股收益4.29美元,归母净利润3.39亿美元,同比去年增长-36.13%
|
| 2025-10-22 |
详情>>
股本变动：
变动后总股本7635.99万股
|
| 2025-10-22 |
财报披露：
美东时间 2025-10-22 盘后发布财报
|
| 2025-07-23 |
详情>>
业绩披露：
2025年中报每股收益4.22美元,归母净利润3.37亿美元,同比去年增长0.83%
|
| 2025-06-11 |
股东大会：
将于2025-07-22召开股东大会
会议内容 ▼▲
- 1.To re-elect, by separate resolutions, the following individuals who retire as Directors and, being eligible, offer themselves for re-election:
1.1 Mr. Ciaran Murray
1.2 Dr. Steve Cutler
1.3 Mr. Ronan Murphy
1.4 Dr. John Climax
1.5 Ms. Julie O’Neill
1.6 Mr. Eugene McCague
1.7 Dr. Linda Grais
1.8 Ms. Anne Whitaker
2.To review the Company's affairs and consider the accounts for the year ended 31 December 2024 and the reports of the Directors and auditors thereon.
3.To ratify the appointment of Ernst & Young (“EY”) as auditors of the Company for the financial year ending 31 December 2025 and to authorise the Board, acting through its Audit Committee, to fix the remuneration of the auditors.
4.That the Directors be and are hereby generally and unconditionally authorised, pursuant to Section 1021 of the Companies Act 2014, to exercise all the powers of the Company to allot relevant securities (within the meaning of Section 1021 of the Companies Act 2014) up to an aggregate nominal amount of 953,805.54 representing approximately 20% of the aggregate
nominal value of the issued ordinary share capital of the Company as at 9 June 2025 and the authority conferred by this resolution shall expire on the earlier of the date of the next Annual General Meeting of the Company or 21 January 2027, unless previously renewed, varied or revoked; provided that the Company may make an offer or agreement before the expiry of the authority conferred by this resolution, which would or might require any such securities to be allotted after the authority conferred by this resolution has expired and, in that case, the Directors may allot relevant securities in pursuance of any such offer or agreement as if the authority conferred hereby had not expired.
5.That, subject to the passing of Resolution 4, the Directors be and are hereby empowered pursuant to Section 1022 and Section 1023(3) of the Companies Act 2014, to allot equity securities (as defined in Section 1023 of the Companies Act 2014) for cash as if the provisions of sub-section (1) of the said Section 1022 did not apply to any such allotment up to an aggregate nominal amount of 476,902.77 representing approximately 10% of the aggregate nominal value of the issued ordinary share capital of the Company as at 9 June 2025 and the authority conferred by this resolution shall expire on the earlier of the date of the next Annual General Meeting of the Company or 21 January 2027, unless previously renewed, varied or revoked; provided that the Company may make an offer or agreement before the expiry of the authority conferred by this resolution, which would or might require any such securities to be allotted after the authority conferred by this resolution has expired and, in that case, the Directors may allot relevant securities in pursuance of any such offer or agreement as if the authority conferred hereby had not expired.
6.That subject to the passing of Resolution 4, the Directors be and they are hereby authorised in addition to any authority granted under Resolution 5, to allot equity securities (as defined in Section 1023 of the Companies Act 2014) for cash as if the provisions of sub-section (1) of the said Section 1022 did not apply to any such allotment provided that:
(i)The proceeds of any such allotment are to be used for the purposes of financing (or refinancing, if the authority is to be used within six months after the original transaction) an acquisition or other capital investment;
(ii)The nominal value of all equity securities allotted pursuant to this authority together with the nominal value of all treasury shares (as defined in Section 106 of the Companies Act 2014) reissued pursuant to Resolution 9 not exceed 476,902.77 representing approximately 10% of the nominal value of the issued share capital as at 9 June 2025.
The authority conferred by this resolution shall expire on the earlier of the date of the next Annual General Meeting of the Company or 21 January 2027, unless previously renewed, varied or revoked; provided that the Company may make an offer or agreement before the expiry of the authority conferred by this resolution, which would or might require any such securities to be allotted after the authority conferred by this resolution has expired and, in that case, the Directors may allot relevant securities in pursuance of any such offer or agreement as if the authority conferred hereby had not expired.
7.That the Company and/or any subsidiary (as such expression is defined by Section 7 of the Companies Act 2014) of the Company be and they are hereby generally authorised to make overseas market purchases (as defined by Section 1072(2) of the Companies Act 2014) of shares of any class of the Company on such terms and conditions and in such manner as the Directors or, as the case may be, the Directors of such subsidiary, may from time to time
determine in accordance with and subject to the provisions of the Companies Act 2014 and the following restrictions and provisions:
(i)The maximum aggregate number of shares authorised to be acquired pursuant to this resolution shall not exceed 10% of the aggregate number of shares issued by the Company at close of business on the date of passing of this resolution;
(ii)The minimum price (exclusive of expenses) which may be paid for any such share shall be an amount equal to the nominal value thereof;
(iii)The maximum price (exclusive of expenses) to be paid for any ordinary share shall be an amount equal to 115% of the NASDAQ Official Closing Price (the “NOCP”) (as reported by NASDAQ) of the Company’s ordinary shares on the trading day preceding the day on which the relevant shares are purchased by the Company.
The authority hereby conferred shall expire on the earlier of the date of the next Annual General Meeting of the Company or 21 January 2027 or (if earlier) unless previously varied, revoked or renewed in accordance with the provisions of Section 1074 of the Companies Act 2014. The Company or any subsidiary may before such expiry make a contract for the purchase of shares which would or might be wholly or partly executed after such expiry and may make a purchase of shares pursuant to any such contract as if the authority hereby conferred had not expired.
8.That the reissue price range at which any treasury shares held by the Company may be reissued off-market shall be as follows:
(i)the maximum price at which such treasury share may be reissued off-market shall be an amount equal to 120% of the “market price”;
(ii)the minimum price at which a treasury share may be reissued off-market shall be the nominal value of the share where such a share is required to satisfy an obligation under an employee share plan operated by the Company or, in all other cases, an amount equal to 95% of the “market price”;
(iii)for the purposes of this resolution, the “market price” shall mean the average closing price per ordinary share of the Company, as reported by NASDAQ, for the thirty (30) trading days immediately preceding the proposed date of reissuance.
The authority hereby conferred to reissue treasury shares shall expire eighteen months from the date of the passing of this resolution unless previously varied or renewed in accordance with the provisions of Section 1078 of the Companies Act 2014.
|
| 2025-05-02 |
详情>>
业绩披露：
2025年一季报每股收益1.91美元,归母净利润1.54亿美元,同比去年增长-17.76%
|
| 2025-02-21 |
详情>>
业绩披露：
2022年年报每股收益6.20美元,归母净利润5.05亿美元,同比去年增长229.87%
|
| 2025-02-21 |
详情>>
业绩披露：
2024年年报每股收益9.60美元,归母净利润7.91亿美元,同比去年增长29.26%
|
| 2024-10-23 |
详情>>
业绩披露：
2024年三季报(累计)每股收益6.43美元,归母净利润5.31亿美元,同比去年增长34.24%
|
| 2024-07-25 |
详情>>
业绩披露：
2024年中报每股收益4.04美元,归母净利润3.34亿美元,同比去年增长43.96%
|
| 2024-06-10 |
股东大会：
将于2024-07-23召开股东大会
会议内容 ▼▲
- 1.To re-elect, by separate resolutions, the following individuals who retire as Directors and, being eligible, offer themselves for re-election:1.1 Mr. Ciaran Murray; 1.2 Dr. Steve Cutler; 1.3 Mr. Ronan Murphy; 1.4 Dr. John Climax; 1.5 Ms. Julie O’Neill; 1.6 Mr. Eugene McCague; 1.7Dr. Linda Grais.
2.To review the Company's affairs and consider the accounts for the year ended 31st December 2023 and the reports of the Directors and auditors thereon.
3.To authorise the Directors to fix the remuneration of the auditors.
4.That the Directors be and are hereby generally and unconditionally authorised, pursuant to Section 1021 of the Companies Act 2014, to exercise all the powers of the Company to allot relevant securities (within the meaning of Section 1021 of the Companies Act 2014) up to an aggregate nominal amount of 993,699.82 representing approximately 20% of the aggregate nominal value of the issued ordinary share capital of the Company as at 7 June 2024 and the authority conferred by this resolution shall expire on the earlier of the date of the next Annual General Meeting of the Company or 22 January 2026, unless previously renewed, varied or revoked; provided that the Company may make an offer or agreement before the expiry of the authority conferred by this resolution, which would or might require any such securities to be allotted after the authority conferred by this resolution has expired and, in that case, the Directors may allot relevant securities in pursuance of any such offer or agreement as if the authority conferred hereby had not expired.
5.That, subject to the passing of Resolution 4, the Directors be and are hereby empowered pursuant to Section 1022 and Section 1023(3) of the Companies Act 2014, to allot equity securities (as defined in Section 1023 of the Companies Act 2014) for cash as if the provisions of sub-section (1) of the said Section 1022 did not apply to any such allotment up to an aggregate nominal amount of 496,849.91 representing approximately 10% of the aggregate nominal value of the issued ordinary share capital of the Company as at 7 June 2024 and the authority conferred by this resolution shall expire on the earlier of the date of the next Annual General Meeting of the Company or 22 January 2026, unless previously renewed, varied or revoked; provided that the Company may make an offer or agreement before the expiry of the authority conferred by this resolution, which would or might require any such securities to be allotted after the authority conferred by this resolution has expired and, in that case, the Directors may allot relevant securities in pursuance of any such offer or agreement as if the authority conferred hereby had not expired.
6.That subject to the passing of Resolution 4, the Directors be and they are hereby authorised in addition to any authority granted under Resolution 5, to allot equity securities (as defined in Section 1023 of the Companies Act 2014) for cash as if the provisions of sub-section (1) of the said Section 1022 did not apply to any such allotment provided that: (i)The proceeds of any such allotment are to be used for the purposes of financing (or refinancing, if the authority is to be used within six months after the original transaction) an acquisition or other capital investment; and (ii)The nominal value of all equity securities allotted pursuant to this authority together with the nominal value of all treasury shares (as defined in Section 106 of the Companies Act 2014) reissued pursuant to Resolution 8 not exceed 496,849.91 representing approximately 10% of the nominal value of the issued share capital as at 7 June 2024.
7.That the Company and/or any subsidiary (as such expression is defined by Section 7 of the Companies Act 2014) of the Company be and they are hereby generally authorised to make overseas market purchases (as defined by Section 1072(2) of the Companies Act 2014) of shares of any class of the Company on such terms and conditions and in such manner as the Directors or, as the case may be, the Directors of such subsidiary, may from time to time determine in accordance with and subject to the provisions of the Companies Act 2014 and the following restrictions and provisions: (i)The maximum aggregate number of shares authorised to be acquired pursuant to this resolution shall not exceed 10% of the aggregate number of shares issued by the Company at close of business on the date of passing of this resolution; (ii)The minimum price (exclusive of expenses) which may be paid for any such share shall be an amount equal to the nominal value thereof; and (iii)The maximum price (exclusive of expenses) to be paid for any ordinary share shall be an amount equal to 115% of the NASDAQ Official Closing Price (the “NOCP”) (as reported by NASDAQ) of the Company’s ordinary shares on the trading day preceding the day on which the relevant shares are purchased by the Company.
8.That the reissue price range at which any treasury shares held by the Company may be reissued off-market shall be as follows: (i)the maximum price at which such treasury share may be reissued off-market shall be an amount equal to 120% of the “market price”; (ii)the minimum price at which a treasury share may be reissued off-market shall be the nominal value of the share where such a share is required to satisfy an obligation under an employee share plan operated by the Company or, in all other cases, an amount equal to 95% of the “market price”; and (iii)for the purposes of this resolution, the “market price” shall mean the average closing price per ordinary share of the Company, as reported by NASDAQ, for the thirty (30) trading days immediately preceding the proposed date of reissuance.
|
| 2024-04-24 |
详情>>
业绩披露：
2024年一季报每股收益2.27美元,归母净利润1.87亿美元,同比去年增长60.68%
|
| 2024-02-23 |
详情>>
业绩披露：
2023年年报每股收益7.46美元,归母净利润6.12亿美元,同比去年增长21.18%
|
| 2023-10-25 |
详情>>
业绩披露：
2023年三季报(累计)每股收益4.83美元,归母净利润3.96亿美元,同比去年增长2.08%
|
| 2023-06-12 |
股东大会：
将于2023-07-25召开股东大会
会议内容 ▼▲
- 1.To re-elect, by separate resolutions, the following individuals who retire as Directors and, being eligible, offer themselves for re-election.
2.To review the Company's affairs and consider the accounts for the year ended 31st December 2022 and the reports of the Directors and auditors thereon.
3.To authorise the Directors to fix the remuneration of the auditors.
4.That the Directors be and are hereby generally and unconditionally authorised, pursuant to Section 1021 of the Companies Act 2014, to exercise all the powers of the Company to allot relevant securities (within the meaning of Section 1021 of the Companies Act 2014) up to an aggregate nominal amount of 984,882.47 representing approximately 20% of the aggregate nominal value of the issued ordinary share capital of the Company as at 7 June 2023 and the authority conferred by this resolution shall expire on the earlier of the date of the next Annual General Meeting of the Company or 24 January 2025, unless previously renewed, varied or revoked; provided that the Company may make an offer or agreement before the expiry of the authority conferred by this resolution, which would or might require any such securities to be allotted after the authority conferred by this resolution has expired and, in that case, the Directors may allot relevant securities in pursuance of any such offer or agreement as if the authority conferred hereby had not expired.
5.That, subject to the passing of Resolution 4, the Directors be and are hereby empowered pursuant to Section 1022 and Section 1023(3) of the Companies Act 2014, to allot equity securities (as defined in Section 1023 of the Companies Act 2014) for cash as if the provisions of sub-section (1) of the said Section 1022 did not apply to any such allotment up to an aggregate nominal amount of 984,882.47 representing approximately 20% of the aggregate nominal value of the issued ordinary share capital of the Company as at 7 June 2023 and the authority conferred by this resolution shall expire on the earlier of the date of the next Annual General Meeting of the Company or 24 January 2025, unless previously renewed, varied or revoked; provided that the Company may make an offer or agreement before the expiry of the authority conferred by this resolution, which would or might require any such securities to be allotted after the authority conferred by this resolution has expired and, in that case, the Directors may allot relevant securities in pursuance of any such offer or agreement as if the authority conferred hereby had not expired.
6.That the Company and/or any subsidiary (as such expression is defined by Section 7 of the Companies Act 2014) of the Company be and they are hereby generally authorised to make overseas market purchases (as defined by Section 1072(2) of the Companies Act 2014) of shares of any class of the Company on such terms and conditions and in such manner as the Directors or, as the case may be, the Directors of such subsidiary, may from time to time determine in accordance with and subject to the provisions of the Companies Act 2014 and the following restrictions and provisions:(i)The maximum aggregate number of shares authorised to be acquired pursuant to this resolution shall not exceed 10% of the aggregate number of shares issued by the Company at close of business on the date of passing of this resolution;(ii)The minimum price (exclusive of expenses) which may be paid for any such share shall be an amount equal to the nominal value thereof;(iii)The maximum price (exclusive of expenses) to be paid for any ordinary share shall be an amount equal to 115% of the NASDAQ Official Close Price (the “NOCP”) (as reported by NASDAQ) of the Company’s ordinary shares on the trading day preceding the day on which the relevant shares are purchased by the Company.
7.That the reissue price range at which any treasury shares held by the Company may be reissued off-market shall be as follows:(i)the maximum price at which such treasury share may be reissued off-market shall be an amount equal to 120% of the “market price;(ii)the minimum price at which a treasury share may be reissued off-market shall be the nominal value of the share where such a share is required to satisfy an obligation under an employee share plan operated by the Company or, in all other cases, an amount equal to 95% of the “market price”;(iii)for the purposes of this resolution, the “market price” shall mean the average closing price per ordinary share of the Company, as reported by NASDAQ, for the thirty (30) trading days immediately preceding the proposed date of reissuance.
|
| 2022-06-17 |
股东大会：
将于2022-06-26召开股东大会
会议内容 ▼▲
- Ordinary Business
1.To re-elect, by separate resolutions, the following individuals who retire as Directors in accordance with the Constitution of the Company and, being eligible, offer themselves for re-election:
1.1Dr. Steve Cutler
1.2Dr. John Climax
1.3Mr. Ronan Murphy
2.To review the Company's affairs and consider the accounts for the year ended 31st December 2021 and the reports of the Directors and auditors thereon.
3.To authorise the Directors to fix the remuneration of the auditors.
Special Business
4.“That the Directors be and are hereby generally and unconditionally authorised, pursuant to Section 1021 of the Companies Act 2014, to exercise all the powers of the Company to allot relevant securities (within the meaning of Section 1021 of the Companies Act 2014) up to an aggregate nominal amount of 978,059.15 representing approximately 20% of the aggregate nominal value of the issued ordinary share capital of the Company as at 6 June 2022 and the authority conferred by this resolution shall expire on the earlier of the date of the next Annual General Meeting of the Company or 25 January 2024, unless previously renewed, varied or revoked; provided that the Company may make an offer or agreement before the expiry of the authority conferred by this resolution, which would or might require any such securities to be allotted after the authority conferred by this resolution has expired and, in that case, the Directors may allot relevant securities in pursuance of any such offer or agreement as if the authority conferred hereby had not expired.
5.“That, subject to the passing of Resolution 4, the Directors be and are hereby empowered pursuant to Section 1022 and Section 1023(3) of the Companies Act 2014, to allot equity securities (as defined in Section 1023 of the Companies Act 2014) for cash as if the provisionsof sub-section (1) of the said Section 1022 did not apply to any such allotment up to an aggregate nominal amount of 244,514.79 representing approximately 5% of the aggregate nominal value of the issued ordinary share capital of the Company as at 6 June 2022 and the authority conferred by this Resolution shall expire on the earlier of the date of the next Annual General Meeting of the Company or 25 January 2024, unless previously renewed, varied or revoked; provided that the Company may make an offer or agreement before the expiry of the authority conferred by this resolution, which would or might require any such securities to be allotted after the authority conferred by this resolution has expired and, in that case, the Directors may allot relevant securities in pursuance of any such offer or agreement as if the authority conferred hereby had not expired.”
6.“That subject to the passing of Resolution 4, the Directors be and they are hereby authorised in addition to any authority granted under Resolution 5, to allot equity securities (as defined in Section 1023 of the Companies Act 2014) for cash as if the provisions of sub-section (1) of the said Section 1022 did not apply to any such allotment provided that:
(i)The proceeds of any such allotment are to be used for the purposes of financing (or refinancing, if the authority is to be used within six months after the original transaction) an acquisition or other capital investment;
(ii)The nominal value of all equity securities allotted pursuant to this authority together with the nominal value of all treasury shares (as defined in Section 106 of the Companies Act 2014) reissued pursuant to Resolution 8 not exceed 244,514.79 representing approximately 5% of the nominal value of the issued share capital as at 6 June 2022.
7.“That the Company and/or any subsidiary (as such expression is defined by Section 7 of the Companies Act 2014) of the Company be and they are hereby generally authorised to make overseas market purchases (as defined by Section 1072(2) of the Companies Act 2014) of shares of any class of the Company on such terms and conditions and in such manner as the Directors or, as the case may be, the Directors of such subsidiary, may from time to time determine in accordance with and subject to the provisions of the Companies Act 2014 and the following restrictions and provisions:
(i)The maximum aggregate number of shares authorised to be acquired pursuant to this resolution shall not exceed 10% of the aggregate number of shares issued by the Company at close of business on the date of passing of this resolution;
(ii)The minimum price (exclusive of expenses) which may be paid for any such share shall be an amount equal to the nominal value thereof;
(iii)The maximum price (exclusive of expenses) to be paid for any ordinary share shall be an amount equal to 115% of the NASDAQ Official Close Price (the “NOCP”) (as reported by NASDAQ) of the Company’s ordinary shares on the trading day preceding the day on which the relevant shares are purchased by the Company.
8.“That the reissue price range at which any treasury shares held by the Company may be reissued off-market shall be as follows:
(i)the maximum price at which such treasury share may be reissued off-market shall be an amount equal to 120% of the “market price”;
(ii)the minimum price at which a treasury share may be reissued off-market shall be the nominal value of the share where such a share is required to satisfy an obligation under an employee share plan operated by the Company or, in all other cases, an amount equal to 95% of the “market price”;
(iii)for the purposes of this resolution, the “market price” shall mean the average closing price per ordinary share of the Company, as reported by NASDAQ, for the thirty (30) trading days immediately preceding the proposed date of reissuance.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-06-16 |
股东大会：
将于2021-07-20召开股东大会
会议内容 ▼▲
- ORDINARY BUSINESS
1.To re-elect, by separate resolutions, the following individuals who retire as Directors in accordance with the Constitution of the Company and, being eligible, offer themselves for re-election:
1.1.Mr. Ciaran Murray;
1.2.Ms. Joan Garahy;
1.3.Mr. Eugene McCague.
2.Subject to and conditional upon completion of the acquisition by ICON of PRA Health Sciences, Inc. having occurred before the start of the AGM, to elect, by separate resolutions, the following individuals who retire as Directors in accordance with the Constitution of the Company and, being eligible, offer themselves for re-election:
2.1.Mr. Colin Shannon;
2.2.Dr. Linda Grais
3.To review the Company's affairs and consider the accounts for the year ended 31st December 2020 and the reports of the Directors and auditors thereon.
4.To authorise the Directors to fix the remuneration of the auditors.
SPECIAL BUSINESS
5.“That the Directors be and are hereby generally and unconditionally authorised, pursuant to Section 1021 of the Companies Act 2014, to exercise all the powers of the Company to allot relevant
securities (within the meaning of Section 1021 of the Companies Act 2014) up to an aggregate nominal amount of euro 635,496.76 representing approximately 20% of the aggregate nominal value of the issued ordinary share capital of the Company as at 10 June 2021 and the authority conferred by this resolution shall (a) expire on the earlier of the date of the next Annual General Meeting of the Company or 19 January 2023, unless previously renewed, varied or revoked; provided that the Company may make an offer or agreement before the expiry of the authority conferred by this resolution, which would or might require any such securities to be allotted after the authority conferred by this resolution has expired and, in that case, the Directors may allot relevant securities in pursuance of any such offer or agreement as if the authority conferred hereby had not expired and (b) be without prejudice and in addition to the authority under the said Section 1021 granted to the Directors pursuant to an ordinary resolution passed at an extraordinary meeting of ICON held on 15 June 2021.”
6.“That, subject to the passing of Resolution 5, the Directors be and are hereby empowered pursuant to Section 1022 and Section 1023(3) of the Companies Act 2014, to allot equity securities (as defined in Section 1023 of the Companies Act 2014) for cash as if the provisions of sub-section (1) of the said Section 1022 did not apply to any such allotment up to an aggregate nominal amount of euro 158,874.19 representing approximately 5% of the aggregate nominal value of the issued ordinary share capital of the Company as at 10 June 2021 and the authority conferred by this Resolution shall expire on the earlier of the date of the next Annual General Meeting of the Company or 19 January 2023, unless previously renewed, varied or revoked; provided that the Company may make an offer or agreement before the expiry of the authority conferred by this resolution, which would or might require any such securities to be allotted after the authority conferred by this resolution has expired and, in that case, the Directors may allot relevant securities in pursuance of any such offer or agreement as if the authority conferred hereby had not expired.”
7.“That subject to the passing of Resolution 5, the Directors be and they are hereby authorised in addition to any authority granted under Resolution 6, to allot equity securities (as defined in Section 1023 of the Companies Act 2014) for cash as if the provisions of sub-section (1) of the said Section 1022 did not apply to any such allotment provided that;
(i)The proceeds of any such allotment are to be used for the purposes of financing (or refinancing, if the authority is to be used within six months after the original transaction) an acquisition or other capital investment;
(ii)The nominal value of all equity securities allotted pursuant to this authority together with the nominal value of all treasury shares (as defined in Section 106 of the Companies Act 2014) reissued pursuant to Resolution 8 not exceed euro 158,874.19 representing approximately 5% of the nominal value of the issued share capital as at 10 June 2021.
8.“That the Company and/or any subsidiary (as such expression is defined by Section 7 of the Companies Act 2014) of the Company be and they are hereby generally authorised to make overseas
7.“That subject to the passing of Resolution 5, the Directors be and they are hereby authorised in addition to any authority granted under Resolution 6, to allot equity securities (as defined in Section 1023 of the Companies Act 2014) for cash as if the provisions of sub-section (1) of the said Section 1022 did not apply to any such allotment provided that:
(i)The maximum aggregate number of shares authorised to be acquired pursuant to this resolution shall not exceed 10% of the aggregate number of shares issued by the Company at close of business on the date of passing of this resolution;
(ii)The minimum price (exclusive of expenses) which may be paid for any such share shall be an amount equal to the nominal value thereof;
(iii)The maximum price (exclusive of expenses) to be paid for any ordinary share shall be an amount equal to 115% of the NASDAQ Official Close Price (the “NOCP”) (as reported by NASDAQ) of the Company’s ordinary shares on the trading day preceding the day on which the relevant shares are purchased by the Company.
9.“That the reissue price range at which any treasury shares held by the Company may be reissued off-market shall be as follows:
(i)the maximum price at which such treasury share may be reissued off-market shall be an amount equal to 120% of the “market price”;
(ii)the minimum price at which a treasury share may be reissued off-market shall be the nominal value of the share where such a share is required to satisfy an obligation under an employee share plan operated by the Company or, in all other cases, an amount equal to 95% of the “market price”;
(iii)for the purposes of this resolution, the “market price” shall mean the average closing price per ordinary share of the Company, as reported by NASDAQ, for the thirty (30) trading days immediately preceding the proposed date of reissuance.
|
| 2021-04-28 |
股东大会：
将于2021-06-15召开股东大会
会议内容 ▼▲
- 1.The ICON share issuance proposal.“That, subject to applicable rules and listing standards of Nasdaq, the Directors of ICON be and they are hereby generally and unconditionally authorized pursuant to section 1021 of the Companies Act 2014 to exercise all the powers of ICON to allot relevant securities (within the meaning of section 1021 of the Companies Act 2014) as contemplated by the Agreement and Plan of Merger, dated as of February 24, 2021 (as it may be amended from time to time), which is referred to as the merger agreement, by and among ICON, ICON US Holdings Inc., Indigo Merger Sub, Inc. and PRA Health Sciences, Inc., up to an aggregate nominal amount of ICON ordinary shares necessary for purposes of satisfying the aggregate issuance of ICON ordinary shares in connection with and pursuant to the merger agreement, provided that such authority shall (a) expire on December 31, 2022, or such later date as may be determined by the ICON board of directors from time to time (provided that under the Companies Act, such later date cannot be more than 5 years after the date on which this resolution is passed), and (b) be without prejudice and in addition to the authority under the said Section 1021 previously granted to the ICON board of directors pursuant to an ordinary resolution passed at the annual general meeting of ICON held on July 21, 2020.”;
2.The ICON adjournment proposal.“That the Chairperson of the meeting be and is hereby authorized to adjourn the meeting to another time and place if, in the discretion of the Chairperson, it is necessary or appropriate to, among other things, solicit additional proxies if there are insufficient votes received by way of proxy, at the time of the meeting to approve the ICON share issuance proposal.”
|
| 2020-06-09 |
股东大会：
将于2020-07-21召开股东大会
会议内容 ▼▲
- ORDINARY BUSINESS
To consider and, if thought fit, pass the following ordinary resolutions:
1.To re-elect, by separate resolutions, the following individuals who retire as Directors in accordance with the Constitution of the Company and, being eligible, offer themselves for re-election:
1.1Ms. Mary Pendergast;
1.2Professor Hugh Brady;
1.3Mr. Ronan Murphy;
1.4Ms. Julie O' Neill
2.To review the Company's affairs and consider the accounts for the year ended 31st December 2019 and the reports of the Directors and auditors thereon.
3.To authorise the Directors to fix the remuneration of the auditors.
SPECIAL BUSINESS
To consider and, if thought fit, pass the following ordinary resolution:
4."That the Directors be and are hereby generally and unconditionally authorised, pursuant to Section 1021 of the Companies Act 2014, to exercise all the powers of the Company to allot relevant securities (within the meaning of Section 1021 of the Companies Act 2014) up to an aggregate nominal amount of 631,548.43 representing approximately 20% of the aggregate nominal value of the issued ordinary share capital of the Company as at 7 June 2020 and the authority conferred by this resolution shall expire on the earlier of the date of the next Annual General Meeting of the Company or 20 January 2022, unless previously renewed, varied or revoked; provided that the Company may make an offer or agreement before the expiry of the authority conferred by this resolution, which would or might require any such securities to be allotted after the authority conferred by this resolution has expired and, in that case, the Directors may allot relevant securities in pursuance of any such offer or agreement as if the authority conferred hereby had not expired."
To consider and, if thought fit, pass the following special resolutions:
5.“That, subject to the passing of Resolution 4, the Directors be and are hereby empowered pursuant to Section 1022 and Section 1023(3) of the Companies Act 2014, to allot equity securities (as defined in Section 1023 of the Companies Act 2014) for cash as if the provisions of sub-section (1) of the said Section 1022 did not apply to any such allotment up to an aggregate nominal amount of 157,887.11 representing approximately 5% of the aggregate nominal value of the issued ordinary share capital of the Company as at 7 June 2020 and the authority conferred by this Resolution shall expire on the earlier of the date of the next Annual General Meeting of the Company or 20 January 2022, unless previously renewed, varied or revoked; provided that the Company may make an offer or agreement before the expiry of the authority conferred by this resolution, which would or might require any such securities to be allotted after the authority conferred by this resolution has expired and, in that case, the Directors may allot relevant securities in pursuance of any such offer or agreement as if the authority conferred hereby had not expired."
6."That subject to the passing of Resolution 4, the Directors be and they are hereby authorised in addition to any authority granted under Resolution 5, to allot equity securities (as defined in Section 1023 of the Companies Act 2014) for cash as if the provisions of sub-section (1) of the said Section 1022 did not apply to any such allotment provided that:
6.1the proceeds of any such allotment are to be used for the purposes of financing (or refinancing, if the authority is to be used within six months after the original transaction) an acquisition or other capital investment;
6.2the nominal value of all equity securities allotted pursuant to this authority together with the nominal value of all treasury shares (as defined in Section 106 of the Companies Act 2014) reissued pursuant to Resolution 8 not exceed 157,887.11 representing approximately 5% of the nominal value of the issued share capital as at 7 June 2020.
The authority conferred by this resolution shall expire on the earlier of the date of the next Annual General Meeting of the Company or 20 January 2022, unless previously renewed, varied or revoked; provided that the Company may make an offer or agreement before the expiry of the authority conferred by this resolution, which would or might require any such securities to be allotted after the authority conferred by this resolution has expired and, in that case, the Directors may allot relevant securities in pursuance of any such offer or agreement as if the authority conferred hereby had not expired."
7.“That the Company and/or any subsidiary (as such expression is defined by Section 7 of the Companies Act 2014) of the Company be and they are hereby generally authorised to make overseas market purchases (as defined by Section 1072(2) of the Companies Act 2014) of shares of any class of the Company on such terms and conditions and in such manner as the Directors or, as the case may be, the Directors of such subsidiary, may from time to time determine in accordance with and subject to the provisions of the Companies Act 2014 and the following restrictions and provisions:
(i)The maximum aggregate number of shares authorised to be acquired pursuant to this resolution shall not exceed 10% of the aggregate number of shares issued by the Company at close of business on the date of passing of this resolution;
(ii)The minimum price (exclusive of expenses) which may be paid for any such share shall be an amount equal to the nominal value thereof;
(iii)The maximum price (exclusive of expenses) to be paid for any ordinary share shall be an amount equal to 115% of the NASDAQ Official Close Price (the “NOCP”) (as reported by NASDAQ) of the Company’s ordinary shares on the trading day preceding the day on which the relevant shares are purchased by the Company.
The authority hereby conferred shall expire on the earlier of the date of the next Annual General Meeting of the Company or 20 January 2022 or (if earlier) unless previously varied, revoked or renewed in accordance with the provisions of Section 1074 of the Companies Act 2014. The Company or any subsidiary may before such expiry make a contract for the purchase of shares which would or might be wholly or partly executed after such expiry and may make a purchase of shares pursuant to any such contract as if the authority hereby conferred had not expired.”
8.“That the reissue price range at which any treasury shares held by the Company may be reissued off-market shall be as follows:
(a)the maximum price at which such treasury share may be reissued off-market shall be an amount equal to 120% of the "market price";
(b)the minimum price at which a treasury share may be reissued off-market shall be the nominal value of the share where such a share is required to satisfy an obligation under an employee share plan operated by the Company or, in all other cases, an amount equal to 95% of the "market price";
(c)for the purposes of this resolution, the "market price" shall mean the average closing price per ordinary share of the Company, as reporte by NASDAQ, for the thirty (30) trading days immediately preceding the proposed date of reissuance.
The authority hereby conferred to reissue treasury shares shall expire eighteen months from the date of the passing of this resolution unless previously varied or renewed in accordance with the provisions of Section 1078 of the Companies Act 2014.”
|
| 2019-06-10 |
股东大会：
将于2019-07-23召开股东大会
会议内容 ▼▲
- ORDINARY BUSINESS
To consider and, if thought fit, pass the following ordinary resolutions:
1.To re-elect, by separate resolutions, the following individuals who retire as Directors in accordance with the Constitution of the Company and, being eligible, offer themselves for re-election:
1.1Dr. John Climax;
1.2Dr. Steve Cutler;
1.3Professor William Hall
2.To review the Company's affairs and consider the accounts for the year ended 31st December 2018 and the reports of the Directors and auditors thereon.
3.To authorise the Directors to fix the remuneration of the auditors.
SPECIAL BUSINESS
To consider and, if thought fit, pass the following ordinary resolution:
4."That the Directors be and are hereby generally and unconditionally authorised, pursuant to Section 1021 of the Companies Act 2014, to exercise all the powers of the Company to allot relevant securities (within the meaning of Section 1021 of the Companies Act 2014) up to an aggregate nominal amount of 648,043.32 representing approximately 20% of the aggregate nominal value of the issued ordinary share capital of the Company as at 6 June 2019 and the authority conferred by this resolution shall expire on the earlier of the date of the next Annual General Meeting of the Company or 22 January 2021, unless previously renewed, varied or revoked; provided that the Company may make an offer or agreement before the expiry of the authority conferred by this resolution, which would or might require any such securities to be allotted after the authority conferred by this resolution has expired and, in that case, the Directors may allot relevant securities in pursuance of any such offer or agreement as if the authority conferred hereby had not expired."
To consider and, if thought fit, pass the following special resolutions:
5.“That, subject to the passing of Resolution 4, the Directors be and are hereby empowered pursuant to Section 1022 and Section 1023(3) of the Companies Act 2014, to allot equity securities (as defined in Section 1023 of the Companies Act 2014) for cash as if the provisions of sub-section (1) of the said Section 1022 did not apply to any such allotment up to an aggregate nominal amount of 162,010.83 representing approximately 5% of the aggregate nominal value of the issued ordinary share capital of the Company as at 6 June 2019 and the authority conferred by this Resolution shall expire on the earlier of the date of the next Annual General Meeting of the Company or 22 January 2021, unless previously renewed, varied or revoked; provided that the Company may make an offer or agreement before the expiry of the authority conferred by this resolution, which would or might require any such securities to be allotted after the authority conferred by this resolution has expired and, in that case, the Directors may allot relevant securities in pursuance of any such offer or agreement as if the authority conferred hereby had not expired."
6."That subject to the passing of Resolution 4, the Directors be and they are hereby authorised in addition to any authority granted under Resolution 5, to allot equity securities (as defined in Section 1023 of the Companies Act 2014) for cash as if the provisions of sub-section (1) of the said Section 1022 did not apply to any such allotment provided that:
6.1the proceeds of any such allotment are to be used for the purposes of financing (or refinancing, if the authority is to be used within six months after the original transaction) an acquisition or other capital investment;
6.2the nominal value of all equity securities allotted pursuant to this authority together with the nominal value of all treasury shares (as defined in Section 106 of the Companies Act 2014) reissued pursuant to Resolution 8 not exceed 162,010.83 representing approximately 5% of the nominal value of the issued share capital as at 6 June 2019.
The authority conferred by this resolution shall expire on the earlier of the date of the next Annual General Meeting of the Company or 22 January 2021, unless previously renewed, varied or revoked; provided that the Company may make an offer or agreement before the expiry of the authority conferred by this resolution, which would or might require any such securities to be allotted after the authority conferred by this resolution has expired and, in that case, the Directors may allot relevant securities in pursuance of any such offer or agreement as if the authority conferred hereby had not expired."
7.“That the Company and/or any subsidiary (as such expression is defined by Section 7 of the Companies Act 2014) of the Company be and they are hereby generally authorised to make overseas market purchases (as defined by Section 1072(2) of the Companies Act 2014) of shares of any class of the Company on such terms and conditions and in such manner as the Directors or, as the case may be, the Directors of such subsidiary, may from time to time determine in accordance with and subject to the provisions of the Companies Act 2014 and the following restrictions and provisions:
(i)The maximum aggregate number of shares authorised to be acquired pursuant to this resolution shall not exceed 10% of the aggregate number of shares issued by the Company at close of business on the date of passing of this resolution;
(ii)The minimum price (exclusive of expenses) which may be paid for any such share shall be an amount equal to the nominal value thereof;
(iii)The maximum price (exclusive of expenses) to be paid for any ordinary share shall be an amount equal to 115% of the NASDAQ Official Close Price (the “NOCP”) (as reported by NASDAQ) of the Company’s ordinary shares on the trading day preceding the day on which the relevant shares are purchased by the Company.
The authority hereby conferred shall expire on the earlier of the date of the next Annual General Meeting of the Company or 22 January 2021 or (if earlier) unless previously varied, revoked or renewed in accordance with the provisions of Section 1074 of the Companies Act 2014. The Company or any subsidiary may before such expiry make a contract for the purchase of shares which would or might be wholly or partly executed after such expiry and may make a purchase of shares pursuant to any such contract as if the authority hereby conferred had not expired.”
8.“That the reissue price range at which any treasury shares held by the Company may be reissued off-market shall be as follows:
(a)the maximum price at which such treasury share may be reissued off-market shall be an amount equal to 120% of the "market price";
(b)the minimum price at which a treasury share may be reissued offmarket shall be the nominal value of the share where such a share is required to satisfy an obligation under an employee share plan operated by the Company or, in all other cases, an amount equal to 95% of the "market price";
(c)for the purposes of this resolution, the "market price" shall mean the average closing price per ordinary share of the Company, as reported by NASDAQ, for the thirty (30) trading days immediately preceding the proposed date of reissuance.
The authority hereby conferred to reissue treasury shares shall expire eighteen months from the date of the passing of this resolution unless previously varied or renewed in accordance with the provisions of Section 1078 of the Companies Act 2014.”
|
| 2018-06-12 |
股东大会：
将于2018-07-24召开股东大会
会议内容 ▼▲
- ORDINARY BUSINESS
1.To re-elect, by separate resolutions, the following individuals who retire as Directors in accordance with the Constitution of the Company and, being eligible, offer themselves for re-election:
1.1Mr. Ciaran Murray;
1.2Mr. Declan McKeon;
1.3Mr. Eugene McCague;
1.4Ms. Joan Garahy.
2.To review the Company's affairs and consider the accounts for the year ended 31st December 2017 and the reports of the Directors and auditors thereon.
3.To authorise the Directors to fix the remuneration of the auditors.
SPECIAL BUSINESS
4."That the Directors be and are hereby generally and unconditionally authorised, pursuant to Section 1021 of the Companies Act 2014, to exercise all the powers of the Company to allot relevant securities (within the meaning of Section 1021 of the Companies Act 2014) up to an aggregate nominal amount of 652,591.76 representing approximately 20% of the aggregate nominal value of the issued ordinary share capital of the Company as at 10 June 2018 and the authority conferred by this resolution shall expire on the earlier of the date of the next Annual General Meeting of the Company or 23 January 2020, unless previously renewed, varied or revoked; provided that the Company may make an offer or agreement before the expiry of the authority conferred by this resolution, which would or might require any such securities to be allotted after the authority conferred by this resolution has expired and, in that case, the Directors may allot relevant securities in pursuance of any such offer or agreement as if the authority conferred hereby had not expired."
5.“That, subject to the passing of Resolution 4, the Directors be and are hereby empowered pursuant to Section 1022 and Section 1023(3) of the Companies Act 2014, to allot equity securities (as defined in Section 1023 of the Companies Act 2014) for cash as if the provisions of sub-section (1) of the said Section 1022 did not apply to any such allotment up to an aggregate nominal amount of 163,147.94 representing approximately 5% of the aggregate nominal value of the issued ordinary share capital of the Company as at 10 June 2018 and the authority conferred by this Resolution shall expire on the earlier of the date of the next Annual General Meeting of the Company or 23 January 2020, unless previously renewed, varied or revoked; provided that the Company may make an offer or agreement before the expiry of the authority conferred by this resolution, which would or might require any such securities to be allotted after the authority conferred by this resolution has expired and, in that case, the Directors may allot relevant securities in pursuance of any such offer or agreement as if the authority conferred hereby had not expired."
6."That subject to the passing of Resolution 4, the Directors be and they are hereby authorised in addition to any authority granted under Resolution 5, to allot equity securities (as defined in Section 1023 of the Companies Act 2014) for cash as if the provisions of sub-section (1) of the said Section 1022 did not apply to any such allotment provided that:
a)the proceeds of any such allotment are to be used for the purposes of financing (or refinancing, if the authority is to be used within six months after the original transaction) an acquisition or other capital investment; and
b)the nominal value of all equity securities allotted pursuant to this authority together with the nominal value of all treasury shares (as defined in Section 106 of the Companies Act 2014) reissued pursuant to Resolution 8 not exceed 163,147.94 representing approximately 5% of the nominal value of the issued share capital as at 10 June 2018.
The authority conferred by this resolution shall expire on the earlier of the date of the next Annual General Meeting of the Company or 23 January 2020, unless previously renewed, varied or revoked; provided that the Company may make an offer or agreement before the expiry of the authority conferred by this resolution, which would or might require any such securities to be allotted after the authority conferred by this resolution has expired and, in that case, the Directors may allot relevant securities in pursuance of any such offer or agreement as if the authority conferred hereby had not expired."
7.“That the Company and/or any subsidiary (as such expression is defined by Section 7 of the Companies Act 2014) of the Company be and they are hereby generally authorised to make overseas market purchases (as defined by Section 1072(2) of the Companies Act 2014) of shares of any class of the Company on such terms and conditions and in such manner as the Directors or, as the case may be, the Directors of such subsidiary, may from time to time determine in accordance with and subject to the provisions of the Companies Act 2014 and the following restrictions and provisions:
(i)The maximum aggregate number of shares authorised to be acquired pursuant to this resolution shall not exceed 10% of the aggregate number of shares issued by the Company at close of business on the date of passing of this resolution;
(ii)The minimum price (exclusive of expenses) which may be paid for any such share shall be an amount equal to the nominal value thereof;
(iii)The maximum price (exclusive of expenses) to be paid for any ordinary share shall be an amount equal to 115% of the NASDAQ Official Close Price (the “NOCP”) (as reported by NASDAQ) of the Company’s ordinary shares on the trading day preceding the day on which the relevant shares are purchased by the Company.
The authority hereby conferred shall expire on the earlier of the date of the next Annual General Meeting of the Company or 23 January 2020 or (if earlier) unless previously varied, revoked or renewed in accordance with the provisions of Section 1074 of the Companies Act 2014. The Company or any subsidiary may before such expiry make a contract for the purchase of shares which would or might be wholly or partly executed after such expiry and may make a purchase of shares pursuant to any such cntract as if the authority herby conferred had not expired.”
8.“That the reissue price range at which any treasury shares held by the Company may be reissued off-market shall be as follows:
(a)the maximum price at which such treasury share may be reissued off-market shall be an amount equal to 120% of the "market price";
(b)the minimum price at which a treasury share may be reissued off-market shall be the nominal value of the share where such a share is required to satisfy an obligation under an employee share plan operated by the Company or, in all other cases, an amount equal to 95% of the "market price";
(c)for the purposes of this resolution, the "market price" shall mean the average closing price per ordinary share of the Company, as reported by NASDAQ, for the thirty (30) trading days immediately preceding the proposed date of reissuance.
The authority hereby conferred to reissue treasury shares shall expire eighteen months from the date of the passing of this resolution unless previously varied or renewed in accordance with the provisions of Section 1078 of the Companies Act 2014.”
|
| 2017-06-23 |
股东大会：
将于2017-07-25召开股东大会
会议内容 ▼▲
- 1.To re-elect, by separate resolutions, the following individuals who retire as Directors in accordance with the Articles of Association of the Company and, being eligible, offer themselves for re-election:
1.1 Professor Dermot Kelleher;
1.2 Professor Hugh Brady;
1.3 Ms. Mary Pendergast;
1.4 Mr. Ronan Murphy.
2.To receive and consider the accounts for the year ended 31st December 2016 and the reports of the Directors and auditors thereon.
3.To authorise the Directors to fix the remuneration of the auditors.
|
| 2016-06-10 |
股东大会：
将于2016-07-22召开股东大会
会议内容 ▼▲
- 1. To re-elect, by separate resolutions, the following individuals who retire as Directors in accordance with the Articles of Association of the Company and, being eligible, offer themselves for re-election
2. To receive and consider the accounts for the year ended 31st December 2015 and the reports of the Directors and auditors thereon.
3. To authorise the Directors to fix the remuneration of the auditors.
|